Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Nimodipine + Betahistine vs Betahistine for vertigo
2013-005122-33Phase 2Completed
- Sponsor
- MDM Pharma
- Start
- Jan 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in vertigo comparing Nimodipine + Betahistine with Placebo + Betahistine (2 arms). Primary endpoint: DHI reduction at 4 weeks. Started Jan 2014; status: completed.
02
Drugs
nimodipine
03
Conditions
vertigo
Beyond the preview
Go deeper on 2013-005122-33.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2013-005122-33.